Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE
Launched by UNIVERSITY COLLEGE HOSPITAL GALWAY · Apr 14, 2020
Trial Information
Current as of May 03, 2025
Terminated
Keywords
ClinConnect Summary
Prone positioning (PP) is an adjunctive therapy used that has been proven to save lives in sedated patients with confirmed moderate-severe acute respiratory distress syndrome (ARDS) receiving invasive mechanical ventilation (MV). PP involves placing patients in the prone, i.e. face down position for time periods of up to 16 hours per day. PP promotes lung homogeneity, improves gas exchange and respiratory mechanics permitting reduction of ventilation intensity, and reducing ventilator-induced lung injury (VILI).
Maintaining self-ventilation is associated with increased aeration of dependen...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Suspected or confirmed COVID19 infection
- • Bilateral Infiltrates on CXR
- • SpO2 \<94% on FiO2 40% by either venturi facemask or high flow nasal cannula
- • RR \<40
- • Written informed consent
- Exclusion Criteria:
- • Age \<18
- • Uncooperative or likely to be unable to lie on abdomen for 16 hours
- • Receiving comfort care only
- • Multi-organ failure
- • RR\>40
- • Contraindication to PP (e.g. vomiting, abdominal wound, unstable pelvic/spinal lesions, pregnancy \>20/40 gestation, severe brain injury).
About University College Hospital Galway
University College Hospital Galway (UCHG) is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and trials. As a prominent teaching hospital affiliated with the National University of Ireland, Galway, UCHG integrates cutting-edge medical practices with rigorous scientific inquiry, fostering an environment that supports the development of new therapies and interventions. Committed to enhancing patient care and outcomes, UCHG collaborates with multidisciplinary teams to conduct high-quality clinical trials across various therapeutic areas, ensuring adherence to ethical standards and regulatory compliance. Through its robust research infrastructure, UCHG aims to contribute significantly to the field of medicine and improve the health of communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Galway, , Ireland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials